{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Condition&page=66", "query": { "condition": "Condition", "page": 66 }, "page_size": 10 }, "pagination": { "page": 66, "page_size": 10, "total_count": 152925, "total_pages": 15293, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Condition&page=67&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Condition&page=65&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-28T16:40:02.965Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00277498", "title": "A 12-week, Randomized, Double-masked, Parallel Group Comparison of Evening Dosing With Xalacom in Subjects With Glaucoma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Open Angle Glaucoma", "Ocular Hypertension" ], "interventions": [ { "name": "Xalacom", "type": "DRUG" }, { "name": "Xalatan", "type": "DRUG" }, { "name": "Timolol", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer's Upjohn has merged with Mylan to form Viatris Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 528, "start_date": "2005-12", "completion_date": "2007-06", "has_results": false, "last_update_posted_date": "2021-02-18", "last_synced_at": "2026-10-28T16:40:02.965Z", "location_count": 64, "location_summary": "Birmingham, Alabama • Flagstaff, Arizona • Artesia, California + 52 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Flagstaff", "state": "Arizona" }, { "city": "Artesia", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Newport Beach", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00277498" }, { "nct_id": "NCT01962987", "title": "A Study Comparing Diclofenac Sodium Gel 3% to Solaraze® (Diclofenac Sodium) Gel 3% in the Treatment of Actinic Keratosis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Actinic Keratosis" ], "interventions": [ { "name": "Diclofenac sodium", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Actavis Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 476, "start_date": "2013-03", "completion_date": "2013-09", "has_results": true, "last_update_posted_date": "2020-07-20", "last_synced_at": "2026-10-28T16:40:02.965Z", "location_count": 31, "location_summary": "Fremont, California • Long Beach, California • Newport Beach, California + 27 more", "locations": [ { "city": "Fremont", "state": "California" }, { "city": "Long Beach", "state": "California" }, { "city": "Newport Beach", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "San Ramon", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01962987" }, { "nct_id": "NCT01256398", "title": "Dasatinib Followed by Stem Cell Transplant in Treating Older Patients With Newly Diagnosed Acute Lymphoblastic Leukemia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Acute Lymphoblastic Leukemia", "Adult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1" ], "interventions": [ { "name": "Alemtuzumab", "type": "BIOLOGICAL" }, { "name": "Allogeneic Hematopoietic Stem Cell Transplantation", "type": "PROCEDURE" }, { "name": "Autologous Hematopoietic Stem Cell Transplantation", "type": "PROCEDURE" }, { "name": "Cyclophosphamide", "type": "DRUG" }, { "name": "Cytarabine", "type": "DRUG" }, { "name": "Dasatinib", "type": "DRUG" }, { "name": "Daunorubicin Hydrochloride", "type": "DRUG" }, { "name": "Dexamethasone", "type": "DRUG" }, { "name": "Etoposide Phosphate", "type": "DRUG" }, { "name": "Filgrastim", "type": "BIOLOGICAL" }, { "name": "Fludarabine Phosphate", "type": "DRUG" }, { "name": "In Vitro-Treated Peripheral Blood Stem Cell Transplantation", "type": "PROCEDURE" }, { "name": "Laboratory Biomarker Analysis", "type": "OTHER" }, { "name": "Leucovorin Calcium", "type": "DRUG" }, { "name": "Melphalan", "type": "DRUG" }, { "name": "Mercaptopurine", "type": "DRUG" }, { "name": "Methotrexate", "type": "DRUG" }, { "name": "Pegfilgrastim", "type": "BIOLOGICAL" }, { "name": "Pharmacological Study", "type": "OTHER" }, { "name": "Tacrolimus", "type": "DRUG" }, { "name": "Vincristine Sulfate", "type": "DRUG" } ], "intervention_types": [ "BIOLOGICAL", "PROCEDURE", "DRUG", "OTHER" ], "sponsor": "National Cancer Institute (NCI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 66, "start_date": "2010-12-14", "completion_date": "2021-11-15", "has_results": true, "last_update_posted_date": "2023-04-04", "last_synced_at": "2026-10-28T16:40:02.965Z", "location_count": 101, "location_summary": "Palo Alto, California • Aurora, Colorado • Boulder, Colorado + 68 more", "locations": [ { "city": "Palo Alto", "state": "California" }, { "city": "Aurora", "state": "Colorado" }, { "city": "Boulder", "state": "Colorado" }, { "city": "Boulder", "state": "Colorado" }, { "city": "Colorado Springs", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT01256398" }, { "nct_id": "NCT04164563", "title": "Even-Up to Minimize Secondary Site Pain For Ankle Fracture", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Arthralgia", "Trouble Balancing" ], "interventions": [ { "name": "Even-Up", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Brigham and Women's Hospital", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 6, "start_date": "2019-11-14", "completion_date": "2020-09-10", "has_results": true, "last_update_posted_date": "2022-10-18", "last_synced_at": "2026-10-28T16:40:02.965Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT04164563" }, { "nct_id": "NCT01897363", "title": "Hypoglycemia in Prader-Willi Syndrome", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Prader Willi Syndrome", "Hypoglycemia" ], "interventions": [ { "name": "Infants with Prader-Willi Syndrome", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "University of Florida", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "2 Months", "maximum_age": "12 Months", "sex": "ALL", "summary": "2 Months to 12 Months" }, "enrollment_count": 2, "start_date": "2013-07", "completion_date": "2014-09", "has_results": false, "last_update_posted_date": "2014-09-25", "last_synced_at": "2026-10-28T16:40:02.965Z", "location_count": 1, "location_summary": "Gainesville, Florida", "locations": [ { "city": "Gainesville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01897363" }, { "nct_id": "NCT00993863", "title": "Analgesic Efficacy and Safety of ADL5859 in Subjects With Acute Dental Pain After Third Molar Extraction", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Acute Pain" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "ADL5859 30 mg", "type": "DRUG" }, { "name": "ADL5859 100 mg", "type": "DRUG" }, { "name": "ADL5859 200 mg", "type": "DRUG" }, { "name": "ibuprofen 400 mg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "50 Years", "sex": "ALL", "summary": "18 Years to 50 Years" }, "enrollment_count": 201, "start_date": "2007-06", "completion_date": null, "has_results": false, "last_update_posted_date": "2015-07-17", "last_synced_at": "2026-10-28T16:40:02.965Z", "location_count": 1, "location_summary": "Austin, Texas", "locations": [ { "city": "Austin", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00993863" }, { "nct_id": "NCT07193563", "title": "A Study to Evaluate the Efficacy and Safety of ENX-102 in Participants With Social Anxiety Disorder", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Social Anxiety Disorder (SAD)" ], "interventions": [ { "name": "ENX-102", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Engrail Therapeutics INC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 47, "start_date": "2025-09-05", "completion_date": "2026-03-19", "has_results": false, "last_update_posted_date": "2026-04-08", "last_synced_at": "2026-10-28T16:40:02.965Z", "location_count": 20, "location_summary": "Phoenix, Arizona • La Jolla, California • Los Angeles, California + 16 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "La Jolla", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Oceanside", "state": "California" }, { "city": "Redlands", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT07193563" }, { "nct_id": "NCT01744093", "title": "Doxycycline for COPD in HIV-Infected Patients", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "HIV", "Chronic Obstructive Pulmonary Disease (COPD)", "Emphysema" ], "interventions": [ { "name": "Doxycycline", "type": "DRUG" }, { "name": "Placebo (sugar pill)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Weill Medical College of Cornell University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "18 Years to 85 Years" }, "enrollment_count": 61, "start_date": "2014-12-08", "completion_date": "2020-12-30", "has_results": true, "last_update_posted_date": "2022-07-21", "last_synced_at": "2026-10-28T16:40:02.965Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT01744093" }, { "nct_id": "NCT05979987", "title": "UCLA Health Patient Health Maintenance Text Reminder July 2023", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Health Maintenance", "Diabetes", "Cancer" ], "interventions": [ { "name": "Reminder of preventive care measures", "type": "BEHAVIORAL" }, { "name": "Persuasion via anecdote", "type": "BEHAVIORAL" }, { "name": "Persuasion via anecdote without link", "type": "BEHAVIORAL" }, { "name": "Persuasion via research", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "University of California, Los Angeles", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 6894, "start_date": "2023-07-27", "completion_date": "2024-07-31", "has_results": false, "last_update_posted_date": "2025-07-02", "last_synced_at": "2026-10-28T16:40:02.965Z", "location_count": 1, "location_summary": "Los Angeles, California", "locations": [ { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05979987" }, { "nct_id": "NCT03440593", "title": "Indirect Calorimetry Usage and Effect in Ventilator-free Days and Muscle Thickness in Septic Ventilated Patients", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Sepsis", "Critical Illness", "Respiratory Failure", "Nutrition Disorders", "Calorie Deficiency", "Diaphragm Injury", "Quadriceps Muscle Atrophy" ], "interventions": [ { "name": "Caloric delivery will target results of IC measurement.", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Baylor Research Institute", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 25, "start_date": "2018-09-10", "completion_date": "2019-10-03", "has_results": false, "last_update_posted_date": "2020-10-22", "last_synced_at": "2026-10-28T16:40:02.965Z", "location_count": 1, "location_summary": "Dallas, Texas", "locations": [ { "city": "Dallas", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT03440593" } ] }